º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

Northumberland firm Pharma Nord helps with major coronavirus study

Morpeth company is helping university study into whether Vitamin D can improve resistance to respiratory conditions, including Covid-19

Pharma Nord House in Morpeth

Products made by a North East company are being tested as part of a trial that aims to improve protections against Covid-19.

Morpeth Pharma Nord’s Bio-Vitamin D3 supplements will be taken by more than 5,000 people as part of the Coronavit study being conducted by scientists at Queen Mary University of London.

There is growing evidence that vitamin D could reduce the risk of respiratory infections and some recent studies have suggested that people with lower vitamin D levels may be more susceptible to coronavirus.

It is hoped that the London study will establish whether taking Vitamin D supplements will increase people’s ability to survive the illness, with Pharma Nord chosen to taken part because of its long history of helping in clinical trials.

Managing director Bent Henriksen, Pharma Nord º£½ÇÊÓÆµ managing director, said: “To be chosen for one of the most important and high profile clinical trials in recent years is a real accolade for Pharma Nord and the North East and a hugely valuable seal of approval for the quality, safety and bioavailability of our Bio-Vitamin D3.

Bent Henriksen of Pharma Nord

“The scientists at Queen Mary University are doing some amazing work in this field and it will be fascinating to see how the Coronavit study pans out.

“It was vitally important for them to choose a vitamin D supplement with a proven track record in clinical trials and documented evidence of its effectiveness in raising levels of vitamin D in the blood.

“Pharma Nord Bio-Vitamin D3 ticks both boxes in this respect and the fact that it is made to pharmaceutical standards is a further sign of quality which will be crucial when it comes to assessing the results of such a large-scale trial.”